Sajadi Tabassi S Abolghasem, Tafaghodi Mohsen, Jaafari Mahmoud Reza
School of Pharmacy, Mashhad University of Medical Sciences, P.O. Box 91775-1365, Mashhad, Iran.
Int J Pharm. 2008 Aug 6;360(1-2):12-7. doi: 10.1016/j.ijpharm.2008.03.036. Epub 2008 Mar 30.
Poor absorption of protein antigens through the mucosal membranes necessitates the use of mucoadhesive delivery systems. Regarding the advantages of mucosal immunization and also the penetration enhancement potential of dextran microspheres, in this study the adjuvant potential of these microspheres was compared with CpG-ODN. Cross-linked dextran microspheres (CDMs) were loaded with tetanus toxoid (TT). In vitro release studies were performed in a model, simulating the nasal cavity. The immunoreactivity of encapsulated TT was assayed by ELISA. Membrane toxicity and local irritating potential of CDM was examined by erythrocyte hemolysis and nasal administration to human nose, respectively. The various formulations were nasally administered to rabbits (n=4). Alum-adsorbed TT (AATT) was injected as the positive control. The serum IgG and nasal lavage sIgA titers were determined by ELISA method. Serum antitoxin titers were determined by toxin neutralization (TN) bioassay method. Mean diameter of CDM was 128.1+/-25.8 microm. Mean encapsulation efficiency was 20.3+/-3.2% (n=3). Antigenicity of encapsulated TT was 90.5+/-1.8% (n=3) that of original TT. Hemolysis studies showed no membrane disruption by CDM and none of the human subjects reported nasal irritation. Among the nasally immunized animals, the highest antitoxin titers was seen in the group immunized with CDM+TT (P<0.0001). The serum IgG titers of the CDM+TT group was higher than the TT solution group (P<0.05). The adjuvant potentials of CDM and CpG-ODN in inducing IgG titers was not significantly different (P>0.05). The lowest sIgA titers in the bronchial lavage were seen in the group of animals received AATT parenterally. Considering the proper release characteristics, desirable preservation of the antigen activity of TT, good mucoadhesion properties and also safety of CDM+TT, these microspheres could be regarded as an efficient mucosal adjuvant and antigen delivery system. These microspheres could induce very high antitoxin titers following nasal administration, while the CpG-ODN could not induce such titers. The antitoxin titers induced by CDM+TT was 175 times higher than the protective levels.
蛋白质抗原通过黏膜的吸收较差,因此需要使用黏膜黏附递送系统。考虑到黏膜免疫的优势以及葡聚糖微球的渗透增强潜力,在本研究中,将这些微球的佐剂潜力与CpG-ODN进行了比较。用破伤风类毒素(TT)负载交联葡聚糖微球(CDM)。在模拟鼻腔的模型中进行体外释放研究。通过ELISA测定包封的TT的免疫反应性。分别通过红细胞溶血和对人鼻进行鼻腔给药来检查CDM的膜毒性和局部刺激潜力。将各种制剂经鼻给予兔子(n = 4)。注射明矾吸附的TT(AATT)作为阳性对照。通过ELISA方法测定血清IgG和鼻腔灌洗sIgA滴度。通过毒素中和(TN)生物测定法测定血清抗毒素滴度。CDM的平均直径为128.1±25.8微米。平均包封效率为20.3±3.2%(n = 3)。包封的TT的抗原性为原始TT的90.5±1.8%(n = 3)。溶血研究表明CDM未破坏膜,并且没有人类受试者报告鼻腔刺激。在经鼻免疫的动物中,用CDM+TT免疫的组中抗毒素滴度最高(P<0.0001)。CDM+TT组的血清IgG滴度高于TT溶液组(P<0.05)。CDM和CpG-ODN在诱导IgG滴度方面的佐剂潜力没有显著差异(P>0.05)。在经肠胃外给予AATT的动物组中,支气管灌洗中的sIgA滴度最低。考虑到合适的释放特性、TT抗原活性的良好保存、良好的黏膜黏附特性以及CDM+TT的安全性,这些微球可被视为一种有效的黏膜佐剂和抗原递送系统。这些微球经鼻给药后可诱导非常高的抗毒素滴度,而CpG-ODN不能诱导这样的滴度。CDM+TT诱导的抗毒素滴度比保护水平高175倍。